Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023)

Corey C. Foster; Chad G. Rusthoven; David J. Sher; Lawrence Feldman; Mary Pasquinelli; Michael T. Spiotto; Matthew Koshy

doi:10.1016/j.lungcan.2019.04.011

Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023)

Corey C. Foster, Chad G. Rusthoven, David J. Sher, Lawrence Feldman, Mary Pasquinelli, Michael T. Spiotto, Matthew Koshy

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret that the word “survival” was omitted by the publisher from the originally published title. The correct and complete title is, “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis.” The authors would like to apologise for any inconvenience caused.

Original language	English (US)
Pages (from-to)	159
Number of pages	1
Journal	Lung Cancer
Volume	132
DOIs	https://doi.org/10.1016/j.lungcan.2019.04.011
State	Published - Jun 2019
Externally published	Yes

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

Access to Document

10.1016/j.lungcan.2019.04.011

Fingerprint

Dive into the research topics of 'Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023)'. Together they form a unique fingerprint.

Cite this

Foster, C. C., Rusthoven, C. G., Sher, D. J., Feldman, L., Pasquinelli, M., Spiotto, M. T., & Koshy, M. (2019). Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023). Lung Cancer, 132, 159. https://doi.org/10.1016/j.lungcan.2019.04.011

Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023). / Foster, Corey C.; Rusthoven, Chad G.; Sher, David J. et al.
In: Lung Cancer, Vol. 132, 06.2019, p. 159.

Research output: Contribution to journal › Comment/debate › peer-review

Foster, CC, Rusthoven, CG, Sher, DJ, Feldman, L, Pasquinelli, M, Spiotto, MT & Koshy, M 2019, 'Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023)', Lung Cancer, vol. 132, pp. 159. https://doi.org/10.1016/j.lungcan.2019.04.011

Foster CC, Rusthoven CG, Sher DJ, Feldman L, Pasquinelli M, Spiotto MT et al. Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023). Lung Cancer. 2019 Jun;132:159. doi: 10.1016/j.lungcan.2019.04.011

Foster, Corey C. ; Rusthoven, Chad G. ; Sher, David J. et al. / Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival : A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023). In: Lung Cancer. 2019 ; Vol. 132. pp. 159.

@article{a54e55cdd4bf411fbe2ffa2c0be73a91,

title = "Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023)",

abstract = "The authors regret that the word “survival” was omitted by the publisher from the originally published title. The correct and complete title is, “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis.” The authors would like to apologise for any inconvenience caused.",

author = "Foster, {Corey C.} and Rusthoven, {Chad G.} and Sher, {David J.} and Lawrence Feldman and Mary Pasquinelli and Spiotto, {Michael T.} and Matthew Koshy",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier B.V.",

year = "2019",

month = jun,

doi = "10.1016/j.lungcan.2019.04.011",

language = "English (US)",

volume = "132",

pages = "159",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival

T2 - A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April)(2019)162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023)

AU - Foster, Corey C.

AU - Rusthoven, Chad G.

AU - Sher, David J.

AU - Feldman, Lawrence

AU - Pasquinelli, Mary

AU - Spiotto, Michael T.

AU - Koshy, Matthew

PY - 2019/6

Y1 - 2019/6

N2 - The authors regret that the word “survival” was omitted by the publisher from the originally published title. The correct and complete title is, “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis.” The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the word “survival” was omitted by the publisher from the originally published title. The correct and complete title is, “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis.” The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85064629790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064629790&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2019.04.011

DO - 10.1016/j.lungcan.2019.04.011

M3 - Comment/debate

C2 - 31031052

AN - SCOPUS:85064629790

SN - 0169-5002

VL - 132

SP - 159

JO - Lung Cancer

JF - Lung Cancer

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this